LONGLYZA

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic preparations for medical use for humans; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for identifying and diagnosing cardiovascular diseases and conditions; diagnostic pharmaceutical preparations, namely, preparations for increasing the heart rate for diagnostic purposes; aforesaid all for human use